Exchange: OTC·Updated 10:33 AM EST

TTIPF Thiogenesis Therapeutics Corp

$0.4111
$0.0374
(10.01%)
Today
Mkt Cap$28.77M
Vol500.00

About TTIPF

Thiogenesis Therapeutics Corp. engages in the development of novel drug formulations that act as precursors for rare diseases. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada.
50

Neutral Sentiment

How do you feel about TTIPF?

Advertisement|Remove ads.